Reconcile Chewable Tablets for Dogs 1x30, POM-V

Product Description

Reconcile chewable tablets for dogs

Active substance: Fluoxetine

Target species Dogs 3.2 Indications for use for each target species

As an aid in the treatment of separation-related disorders in dogs manifested by destruction and inappropriate behaviours (vocalisation and inappropriate defaecation and/or urination) and only in combination with behavioural modification techniques.

Contraindications Do not use in dogs weighing less than 4kg. Do not use in dogs with epilepsy or in dogs with a history of seizures.

Do not use in case of hypersensitivity to fluoxetine or other Selective Serotonin ReUptake Inhibitors (SSRIs) or to any of the excipients.

Special precautions for safe use in the target species: The safety of the product has not been established in dogs less than 6 months of age or weighing less than 4kg. Though rare, seizures may occur in dogs treated with the veterinary medicinal product. Treatment should be stopped if seizures occur. Special precautions to be taken by the person administering the veterinary medicinal product to animals In case of accidental ingestion, seek medical advice immediately and show the package leaflet or the label to the physician. In humans, the most common symptoms associated with overdose include seizures, somnolence, nausea, tachycardia, and vomiting.

Special precautions for the protection of the environment: Not applicable.

View other products in Behaviour »